Metabolic syndrome and depressive symptoms in a primary health care setting in Turkey;Türkiye'de bir aile hekimliǧi ünitesinde depresyon ve metabolik sendrom ilişkisinin araştırılması

Klinik Psikofarmakoloji Bulteni

Volumn 21, Issue 1, 2011, Pages 49-57

  Demirci, Hakan ^a   Cinar, Yildirim ^b   Bilgel, Nazan ^c  

^a Nilüfer Fethiye Bulvar 9 Nolu Aile Sa li i Merkezi   (Turkey)

^b TRAKYA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^c ULUDAG UNIVERSITY   (Turkey)

Author keywords

Adult population; Depressive symptoms; Family practice; Metabolic syndrome; Turkey

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; BLOOD PRESSURE MEASUREMENT; BODY MASS; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; GENERAL HEALTH QUESTIONNAIRE; GENERAL PRACTICE; GLUCOSE BLOOD LEVEL; HAMILTON SCALE; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; PRIMARY HEALTH CARE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; TURKEY (REPUBLIC); WAIST CIRCUMFERENCE;

EID: 79955579596     PISSN: 10177833     EISSN: 13029657     Source Type: Journal    
DOI: 10.5350/kpb-bcp201121108     Document Type: Article

References (46)

1. Herva A, Rasanen P, Miettunen J, Timonen M, Laksy K, Veijola J, Laitinen J, Ruokonen A, Joukamaa M: Co-occurrence of metabolic syndrome with depression and anxiety in young adults: the Northern Finland 1966 Birth Control Study. Psychosom Med 2006, 68:213-216.
2. Kinder LS, Carnethon MR, Palaniappan LP, King AC, Fortmann SP: Depression and the metabolic syndrome in young adults: findings from the Third National Health and Nutrition Examination Survey. Psychosom Med 2004, 66:316-322.
3. McCaffery JM, Niaura R, Todaro JF, Swan GE, Carmelli D: Depressive symptoms and metabolic risk in adult male twins enrolled in the National Heart Lung and Blood Institute twin study. Psychosom Med 2003, 65:490-497.
4. Miller GE, Freedland KE, Carney RM, Stetler CA, Banks WA: Pathways linking depression, adiposity, and inflammatory markers in healthy young adults. Brain Behav Immun 2003, 17:276-285.
5. Raikkonen K, Matthews KA, Kuller LH: The relationship between psychological risk attributes and the metabolic syndrome in healthy women: antecedent or consequence? Metabolism 2002, 51:1573-1577.
6. Raikkonen K, Matthews KA, Kuller LH: Depressive symptoms and stressful life events predict metabolic syndrome among middle aged women: a comparison of World Health Organization, Adult Treatment Panel III and the International Diabetes Foundation definitions. Diabetes Care 2007, 30:872-877.
7. Vogelzangs N, Suthers K, Ferrucci L, Simonsick EM, Ble A, Schrager M, Bandinelli S, Lauretani F, Giannelli SV, Penninx BW: Hypercortisolemic depression is associated with the metabolic syndrome in late life. Psychoneuroendocrinology 2007, 32:151-159
8. Skilton MR, Moulin P, Terra JL, Bonnet F: Associations between anxiety, depression and the metabolic syndrome. Biol Psychiatry 2007, 62:1251-1257.
9. Dunbar JA, Reddy P, Davis-Lameloise N, Philpot B, Laatikainen T, Kilkkinen A, Bunker S, Best JD, Vartainen E, Kai Lo S, Janus E: Depression: an important comorbidity with metabolic syndrome in a general population. Diabetes Care 2008, 31:2368-2373.
10. Miettola J, Niskanen LK, Viinamaki H, Kumpusalo E: Metabolic syndrome is associated with self-perceived depression. Scand J Prim Health Care 2008, 26:203-210.
11. Hildrum B, Mykletun A, Midthjell K, Ismail K, Dahl AA: No association of depression and anxiety with the metabolic syndrome: the Norwegian HUNT study. Acta Psychiatr Scand 2009, 120:14-22.
12. Akbaraly TN, Kivimaki M, Brunner EJ, Chandola T, Marmot MG, Singh-Manoux A, Ferrie JE: Association between metabolic syndrome and depressive symptoms in middle-aged adults. Results from the Whitehall II study. Diabetes Care 2009, 32:499-504.
13. Takeuchi T, Nakao M, Nomura K, Inoue M, Tsurugano S, Shinozaki Y, Yano E. Association of the metabolic syndrome with depression and anxiety in Japanese men: A 1-year cohort study. Diabetes Metab Res Rev 2009, 25:762-767.
14. Almeida OP, Calver J, Hankey GJ, Flicker L: Obesity and metabolic syndrome increase the risk of incident depression in older men: the health in men study. Am J Geriatr Psychiatry 2009, 17: 889-898.
15. Ahola AJ, Thorn LM, Saraheimo M, Forsblom C, Groop PH. Depression is associated with the metabolic syndrome among patients with type I diabetes. Ann Med 2010, 42:495-501.
16. McIntyre RS, Rasgon NL, Kemp DE et al: Metabolic syndrome and major depressive disorder: co-occurrence and pathophysiologic overlap. Curr Diab Rep 2009, 9:51-59.
17. Hayden BB, Rachel MB, Maren KO, David CS: The association of psychosocial factors and depression with hypertension among older adults. Int J Geriat Psychiatr 2003, 18:1142-1148.
18. Bruce SJ, Peter F, Deborah DI: Are symptoms of anxiety and depression risk factors for hypertension? Arch Fam Med 1997, 6:43-49.
19. Vasiuk IA, Nesterova EA, Dovzhenko TV, Kozina AA, Sadulaeva IA, Tarasova KV: Modern antidepressants in complex management of patients with hypertension and concomitant affective disorders. Kardiologiia 2004, 44:72-79.
20. Sherita HG, Hochang BL, Pamela JS, Ana DR, Annette LF, Moyses S, Constantine L: Depression and type 2 diabetes mellitus: the multiethnic study of atherosclerosis. Psychosom Med 2007, 69:529-536.
21. Talbot F, Nouwen A: A review of the relationship between depression and diabetes in adults: is there a link? Diabetes Care 2000, 23:1556-1562.
22. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ: The prevalence comorbid depression in adults with diabetes: a metaanalysis. Diabetes Care 2001, 24:1069-1078.
23. Perveen S, Otho MS, Siddiqi MN, Hatcher J, Rafique G: Association of depression with newly diagnosed type 2 diabetes among adults aged between 25 to 60 years in Karachi Pakistan. Diabetology & Metabolic Syndrome 2010, 2:17.
24. Sokol MC, McGuian KA, Verbrugge RR, Epstein RS: Impact of medication adherence on hospitalization risk and healthcare. Cos Med Care 2005, 43:521-530.
25. Lehto SM, Niskanen L, Tolmunen T, Hintikka J, Viinamaki H, Heiskanen T, Honkalampi K, Kokkonen M, Kojvumaa-Honkanen H: Low HDL-cholesterol levels are associated with long symptom duration in patients with major depressive disorder. Psychiatry Clin Neurosci 2010, 64:279-283.
26. Vogelzangs N, Kritchevsky SB, Beekman AT, Brenes GA, Newman AB, Satterfield S, Yaffe K, Harris TB, Penninx BW: Health ABC Study: Obesity and onset of significant depressive symptoms: Results from a prospective community based cohort study of older men and women. J Clin Psychiatry 2010, 71:391-399.
27. Oǧuz A. Metabolic syndrome. Klinik Psikofarmakoloji Bülteni - Bulletin of Clinical Psychopharmacology 2008; 18: 57-61
28. Can AS, Bersot T P: Analysis of agreement among definitions of metabolic syndrome in nondiabetic Turkish adults: a methodological study. BMC Public Health 2007,7:353 http://www.biomedcentral.com/1471-2458/7/353
29. Kozan O, Oguz A, Abaci A, Erol C, Ongen Z, Temizhan A, Celik S: Prevalence of the metabolic syndrome among Turkish adults. Eur J Clin Nutr 2007, 6:548-553.
30. Ozsahin AK, Gokcel A, Sezgin N, Akbaba M, Guvener N, Ozisik L, Karademir BM: Prevalence of the metabolic syndrome in a Turkish adult population. Diabetes Nutr Metab 2004, 17: 230-234.
31. Mahley RW, Palaoglu KE, Atak Z, Dawson-Pepin J, Langlois AM, Cheung V, Onat H, Fulks P, Mahley LL, Vakar F: Turkish heart study. Lipids, lipoproteins, and alipoproteins. J Lipid Res 1995, 36: 839-859.
32. Onat A, Ceyhan K, Başar O, Erer B, Toprak S, Sansoy V: Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels a prospective and cross-sectional evaluation. Atherosclerosis 2002, 165:285-292.
33. Turkish Ministry of Health., RSHC, The School of Public Health: National Burden of Disease and Cost Effectiveness Project, Burden of Disease Final Report, December 2004, Ankara, p. 240. [http://www.tusak.saglik.gov.tr/pdf/nbd/raporlar/burdenofdiseaseENG.pdf] , Accessed November 9th, 2010.
34. Sagduyu A, Ogel K, Ozmen E, Boratav C: Depression in Primary Health Care. Turk J Psychiatr 2000, 11:3-16.
35. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterols in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
36. Hisli N Beck depresyon envanterinin geçerliǧi üzerine bir çali{dotless}şma. Psikoloji Dergisi 1988, 6:118-126. [A validation study of Beck Depression Inventory. Psychology Journal 1988, 6:118-126]
37. Kobrosly RW, Van Wijngaarden E. Revisiting the association between metabolic syndrome and depressive symptoms. Ann Epidemiol 2010, 20:852-855.
38. Foley DL, Morley KI, Madden PA, Health AC, Whitfield JB, Martin NG. Major depression and the metabolic syndrome. Twin Res Hum Genet 2010, 13:347-358.
39. Roriz-Cruz M, Rosset I, Wada T. et al. Stroke independent association between metabolic syndrome and functional dependence, depression, and low quality of life in elderly community-dwelling Brazilian people. J Am Geriatr Soc 2007, 55:374-382.
40. Vaccarino V, McClure C, Johnson D, Sheps D, Bittner V, Rutledge T et al. Depression, the metabolic syndrome and cardiovascular risk. Psychosom Med 2008, 70:40-48.
41. East C, Willis BL, Barlow CE, Grannemann BD, FitzGerald SJ, DeFina LF, Trivedi MH. Depressive symptoms and metabolic syndrome in preventive healthcare: the Cooper Center longitudinal study. Metab Syndr Relat Disord 2010, 8:451-457.
42. Altindaǧ A, Demirbaǧ R, Saraçoǧlu G. Quality of life in metabolic syndrome: The impact of comorbid psychiatric disorders. Psychiatry in Turkey 2008, 10(1):29-33 (in Turkish)
43. Savaş E., Özovaci A., Kokaçya M.H., Altindaǧ A., Virit O. Frequency of metabolic syndrome in obsessive compulsive disorder patients on antidepressant monotherapy vs antidepressant plus atypical antipsychotic combination therapy: a naturalistic, descriptive pilot study. Klinik Psikofarmakoloji Bülteni - Bulletin of Clinical Psychopharmacology 2010; 20: 307-313
44. Yumru M, Savaş EH. Gergerlioǧlu S, Başarali K, Kalenderoǧlu A, Savaş HA, Büyükbaş S. The relationship of metabolic syndrome, serum leptin levels and treatment in bipolar disorder. Klinik Psikofarmakoloji Bülteni - Bulletin of Clinical Psychopharmacology 2008; 18: 79-83
45. Usta E, Metin Ö, Birsöz S. Schizophrenia and diabetes mellitus: Diabetes mellitus or metabolic syndrome caused by new generation antipsychotics. Klinik Psikofarmakoloji Bülteni - Bulletin of Clinical Psychopharmacology 2007; 17: 207-216
46. Mete L, Çetinay Ünsal P. Metabolic side effects of new generation antipsychotics. Klinik Psikofarmakoloji Bülteni - Bulletin of Clinical Psychopharmacology 2004; 14: 168-177.